Venture Capital · Toronto (Canada) · Founded 2000
Genesys Capital is a life science venture capital firm that invests in and builds early-stage companies in the high-growth sectors of biotechnology, pharmaceuticals, and medical technology. They have a proven track record of identifying emerging bioscience opportunities and transforming them into commercially successful enterprises.
Seed, Series A, Series B
BioTech, MedTech, Pharma
Adapsyn Bioscience Inc., CryoStasis Inc., EBT Medical, Feldan Therapeutics, Flosonics Medical, Functional Neuromodulation Ltd., Fusion Pharmaceuticals, Giiant Pharma Inc., Inversago Pharma, Profound Medical Inc., Questat Inc., Veralox Therapeutics, Inc., Affinium Pharmaceuticals, Aptinyx Inc., DELEX Therapeutics Inc., Epocal Inc., Excel-Tech Limited, Fairhaven Pharmaceuticals Inc., IDbyDNA, Invitae Corporation, Ionalytics Corporation, Millenium Biologix Corporation, Naurex Inc., Systems Xcellence Inc., Xillix Technologies Corporation